The Vulvar Pain Assessment Questionnaire: Factor Structure, Preliminary Norms, Internal Consistency, and Test-Retest Reliability.
Emma Dargie, Ronald R Holden, Caroline F Pukall
https://pubmed.ncbi.nlm.nih.gov/29198513Actively Recruiting
Led by University of Ottawa · Updated on 2026-05-05
240
Participants Needed
2
Research Sites
56 weeks
Total Duration
U
University of Ottawa
Lead Sponsor
C
Canadian Institutes of Health Research (CIHR)
Collaborating Sponsor
Researchers are evaluating the management of provoked vestibulodynia (PVD), a common type of vulvovaginal pain affecting many women during sexual and non-sexual activities. This trial is a randomized controlled study comparing the effectiveness of photobiomodulation (PBM), multimodal physiotherapy (mPT), and their combination to reduce pain severity and improve related symptoms. The study aims to provide evidence on pain reduction and patient outcomes over time, including follow-ups at 6 months and 1 year. Participants will be randomly assigned to one of four groups: sham PBM (control), real PBM, mPT with sham PBM, and mPT combined with real PBM. The PBM treatment uses a laser system delivering red and infrared light progressively over 15 sessions in 14 weeks, with treatment lasting about 20 minutes each. The mPT involves 10 physiotherapy sessions focusing on education, relaxation, pelvic floor muscle exercises, manual techniques, and vaginal dilator use. Those in combination groups receive both treatments during the same visits. Participants are asked to avoid vaginal penetration during the first 8 weeks. During the study, participants will attend regular treatment sessions and complete assessments including pain questionnaires, sensitivity tests, and sexual function evaluations. Pain severity will be measured at baseline, after treatment, and at 6 and 12 months. Adherence to home exercises and any side effects will be monitored. The study includes close safety oversight, and participants in the sham PBM group will have the option to receive real PBM after the study ends.
CONDITIONS
Biomodulation and Rehabilitation Interventions to tarGet Pelvic Health
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 14 weeks
Participants receive up to 15 photobiomodulation (laser) treatments over 14 weeks, with sessions lasting approximately 20 minutes. Those assigned to multimodal physiotherapy (mPT) will attend 10 physiotherapy sessions over 14 weeks, lasting about 45 minutes each. For participants receiving both interventions, laser and physiotherapy sessions will be coordinated within the same visits where possible. During the first 8 weeks, participants are asked to avoid vaginal penetrative activities. After 8 weeks, they may resume penetrative activities cautiously as tolerated.
Weekly photobiomodulation visits for the first 8 weeks, then additional sessions to complete 15 treatments; multimodal physiotherapy visits weekly for 8 weeks then every two weeks for 2 sessions, totaling 10 sessions
Duration - Up to 12 months
Participants are monitored for outcomes and safety after completing the intervention, with assessments at 2 weeks, 6 months, and 12 months post intervention start.
Visits at approximately 2 weeks, 6 months, and 12 months after intervention start
Total: 2 locations
1
Motor Function Measurement Lab
Ottawa, Ontario, Canada, K1S 1S2
Actively Recruiting
2
Bernard Lab
Québec, Quebec, Canada
Actively Recruiting
L
Linda McLean, PhD
R
Regina Ding, PhD
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
FACTORIAL
Primary Purpose
TREATMENT
Number of Arms
4
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Emma Dargie, Ronald R Holden, Caroline F Pukall
https://pubmed.ncbi.nlm.nih.gov/29198513Kevin E Vowles, Eric S Kruger, Robert W Bailey...
https://pubmed.ncbi.nlm.nih.gov/32816389Carolyn Vandyken, Sandra Hilton
https://pubmed.ncbi.nlm.nih.gov/27498209Katherine LePage, Amanda Selk
https://pubmed.ncbi.nlm.nih.gov/27484917Sophie Bergeron, Yitzchak M Binik, Samir Khalifé...
https://pubmed.ncbi.nlm.nih.gov/11275387Ahinoam Lev-Sagie, Asia Kopitman, Amnon Brzezinski
https://pubmed.ncbi.nlm.nih.gov/28970071Emma E Dargie, Susan M Chamberlain, Caroline F Pukall
https://pubmed.ncbi.nlm.nih.gov/28343555Linda McLean, Stephanie Thibault-Gagnon, Kaylee Brooks...
https://pubmed.ncbi.nlm.nih.gov/27215690Mélanie Morin, Sophie Bergeron, Samir Khalifé...
https://pubmed.ncbi.nlm.nih.gov/24344835Evelyne Gentilcore-Saulnier, Linda McLean, Corrie Goldfinger...
https://pubmed.ncbi.nlm.nih.gov/20059663